Akari Therapeutics, Plc Goodwill
Akari Therapeutics, Plc (AKTX) had Goodwill of $8.43 million as of 2025-12-31, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:Goodwill · last filed 2026-08-13
- 2025-12-31: Goodwill $8.43M.
- 2025-09-30: Goodwill $8.43M.
- 2025-06-30: Goodwill $8.43M.
- 2025-03-31: Goodwill $8.43M.
| Period end | Goodwill |
|---|---|
| 2025-12-31 | $8.43M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $8.43M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $8.43M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $8.43M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $8.43M 10-K · filed 2026-03-30 |
| 2015-09-18 | $19.28M 20-F · filed 2018-07-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ELI LILLY & Co (LLY) | United States | $1,113.804B | 42.28 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |